Langerhans Cell Histiocytosis with Good Response to Low-Dose Imatinib: Case Report and Literature Review
Langerhans cell histiocytosis (LCH) is a rare neoplastic disease characterized by infiltration of histiocytes and dendritic cells into body organs. While treatment is better established in pediatrics, there is still no consensus on therapy in the adult population. Imatinib has shown promising result...
Main Authors: | Mohammed Abdulagayoom, Deena Mudawi, Zsolt Lengyel, Hayan Abo Samra, Awni Alshurafa, Mohamed A. Yassin |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2023-07-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | https://beta.karger.com/Article/FullText/531230 |
Similar Items
Similar Items
-
Langerhans cell histiocytosis limited to the female genital tract: A review of literature with three additional cases
by: Rebekah Wieland, et al.
Published: (2017-11-01) -
Langerhans cell histiocytosis in an adult patient
by: A. E. Karamova, et al.
Published: (2019-10-01) -
Multisystem langerhans cell histiocytosis in adult
by: Anubhav Garg, et al.
Published: (2012-01-01) -
Updates on Erdheim-Chester disease
by: Ismail Elbaz Younes, et al.
Published: (2022-06-01) -
Case report: Common clonal origin of concurrent langerhans cell histiocytosis and acute myeloid leukemia
by: Shintaro Kazama, et al.
Published: (2022-09-01)